Benlysta (Belimumab) Approved for Children With Lupus

05:04 EDT 29 Apr 2019 |

MONDAY, April 29, 2019 -- The intravenous drug Benlysta (belimumab) has been approved by the U.S. Food and Drug Administration to treat children with lupus, a chronic disease that triggers inflammation and damages tissues and organs throughout the...

Original Article: Benlysta (Belimumab) Approved for Children With Lupus


More From BioPortfolio on "Benlysta (Belimumab) Approved for Children With Lupus"

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...